 |
Featured Review Cell Science Reviews Vol 6 No 3 ISSN 1742-8130 |
|
Induced pluripotent stem cells for heart failure
Tanya Medley, Rejhan Idrizi & David Kaye
Heart Failure Research Group, Baker IDI Heart & Diabetes Institute Melbourne, Australia.
Received 15th January © Cell Science 2010
The addition of induced pluripotent stem (iPS) cells to the area of stem cell biology holds great promise for regenerative medicine. These cells, which are by all accounts similar to embryonic stem cells, are simple to derive and differentiate. For cardiovascular research, where researchers often work with limited tissue from human biopsies, the abundance of cells that can be derived from patients using iPS cells could soon see the concept of ‘disease in a dish' become a reality. In addition to studying disease, iPS cells are likely to play a vital role in advancing toxicity studies and eventually in providing a source for cellular replenishment after injury. In this review we summarise the recent progress in iPS cell research, and compare the potential of induced and embryonic stem cells for cardiac regeneration.
Click
to access complete issue ($8.99) and to download full article in
or
formats 